Invictus MD Strategies Corp Share Price Toronto S.E.
Equities
GENE
CA46183X2086
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Sales 2018 | 2.36 3.23 182.44 | Sales 2019 | 4.69 6.42 362.1 | Capitalization | 104M 142M 7.99B |
---|---|---|---|---|---|
Net income 2018 | -19M -25.99M -1.47B | Net income 2019 | -35M -47.87M -2.7B | EV / Sales 2018 | 45,833,024 x |
Net cash position 2018 | 37.59M 51.42M 2.9B | Net Debt 2019 | 3.85M 5.26M 297M | EV / Sales 2019 | 22,877,117 x |
P/E ratio 2018 |
-5.87
x | P/E ratio 2019 |
-2.45
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 6.83% |
Managers | Title | Age | Since |
---|---|---|---|
Imran Haider
CEO | Chief Executive Officer | - | - |
Trevor Dixon
BRD | Director/Board Member | - | 08/05/19 |
Larry Heinzlmeir
IRO | Public Communications Contact | - | 23/01/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Dixon
BRD | Director/Board Member | - | 08/05/19 |
Jagdeep Gupta
BRD | Director/Board Member | - | 21/02/22 |
Greg Macdonald
BRD | Director/Board Member | - | 25/01/21 |
1st Jan change | Capi. | |
---|---|---|
+9.94% | 4.99B | |
-32.21% | 3.61B | |
-1.43% | 3.1B | |
-25.09% | 2.64B | |
-11.46% | 2.32B | |
+36.65% | 1.85B | |
+37.15% | 1.43B | |
-16.01% | 1.39B | |
+40.95% | 1.37B |
- Stock Market
- Equities
- IVITF Stock
- GENE Stock